SEC Company Response from NEURO-HITECH PHARMACEUTICALS INC (CIK 0001328511) — Sep 20, 2005
NEURO-HITECH PHARMACEUTICALS INC (CIK 0001328511)
Date: Sept. 20, 2005 · CIK: 0001328511 · Accession: 0001170423-05-000347
AI Filing Summary & Sentiment
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
NORTHERN WAY RESOURCES, INC.
627 Moberly Road, Suite 601
Vancouver, British Columbia Canada V5Z 4B3
(604) 628-2165, Fax (866) 824-0888
September 20, 2005
U.S. Securities & Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Mail Stop 0305
VIA FAX: 202-942-9648
Attention: Ms. Anita Karu
Dear Sirs:
Re: Registration Statement on Form SB-2 - Request for Acceleration
In accordance with Regulation C, Rule 461, we hereby request acceleration of the
effective date of our registration statement on Form SB-2, as amended, such that
it be deemed effective on Tuesday, September 22, 2005 at 2:30pm (EST), or as
soon as practicable thereafter.
We are aware of our obligations under the Act in this regard and acknowledge
that:
1. should the Commission or the staff, acting pursuant to delegated
authority, declare our filing effective, this does not foreclose the
Commission from taking any action with respect to the filing;
2. the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring our filing effective, does not relieve us from
our full responsibility for the adequacy or accuracy of the disclosure
in our filing; and
3. we may not assert staff comments and the declaration of effectiveness
as a defense in any proceeding initiated by the commission or any
person under the federal securities laws of the United States.
Yours truly,
NORTHERN WAY RESOURCES, INC.
PER: /s/ Keith Andrews
KEITH ANDREWS
President
</TEXT>
</DOCUMENT>